Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

The term 'neuromyelitis optica spectrum disorders'(NMOSD) is used as an umbrella term that
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …

Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …

Background and Objectives Neuromyelitis optica spectrum disorder (NMOSD) is a rare
debilitating autoimmune disease of the CNS. Three monoclonal antibodies were recently …

Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …

Objective To investigate accumulation of disability in neuromyelitis optica spectrum disorder
(NMOSD) and myelin oligodendrocyte glycoprotein‐antibody‐associated disease (MOGAD) …

The clearance function is essential for maintaining brain tissue homeostasis, and the
glymphatic system is the main pathway for removing brain interstitial solutes. Aquaporin-4 …

Background and Objectives Satralizumab, an interleukin 6 receptor inhibitor, reduced the
risk of protocol-defined relapse (PDR) vs placebo in 2 independent, double-blind studies in …

Inebilizumab (Uplizna®) is a recently approved monoclonal antibody for use in adults with
neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody …

Pain is acknowledged as the body alarm system that reminds us of the environmental threat,
muscle damage or the presence of some disease condition (1, 2). The pain is directly related …